Morphometric evidence for bone resorption and replacement in prostate cancer.
暂无分享,去创建一个
[1] J. Dodd,et al. Epidermal growth factor receptor mRNA levels in human prostatic tumors and cell lines. , 1990, The Journal of urology.
[2] J. Varley,et al. Parathyroid-hormone-related protein in tumours associated with hypercalcaemia , 1990, The Lancet.
[3] J. Hayman,et al. Parathyroid hormone‐related protein: Immunohistochemical localization in cancers and in normal skin , 1989, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[4] M. Harada,et al. Establishment of a model to evaluate inhibition of bone resorption induced by human prostate cancer cells in nude mice. , 1988, The Journal of urology.
[5] H. Antoniades,et al. Constitutive production of platelet-derived growth factor-like proteins by human prostate carcinoma cell lines. , 1988, Cancer research.
[6] M. Drezner,et al. Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committee , 1987, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[7] J. Kanis,et al. Biochemical and histological evidence that carcinoma of the prostate is associated with increased bone resorption. , 1987, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[8] R. Percival. Skeletal effects of carcinoma of the breast and prostate. , 1986, Annals of the Royal College of Surgeons of England.
[9] J. Kanis,et al. Generalised increase in bone resorption in carcinoma of the prostate. , 1985, British journal of urology.
[10] Gideon,et al. Factors associated with humoral hypercalcemia of malignancy stimulate adenylate cyclase in osteoblastic cells. , 1983, The Journal of clinical investigation.
[11] S. Jacobs. Spread of prostatic cancer to bone. , 1983, Urology.
[12] M. Chapuy,et al. Histomorphometric analysis of sclerotic bone metastases from prostatic carcinoma with special reference to osteomalacia , 1983, Cancer.
[13] H. Antoniades,et al. Platelet-derived growth factor stimulates bone resorption via a prostaglandin-mediated mechanism. , 1982, Endocrinology.
[14] E. Canalis,et al. Direct stimulation of bone resorption by epidermal growth factor. , 1980, Endocrinology.
[15] G. Mundy,et al. Direct resorption of bone by human breast cancer cells in vitro , 1978, Nature.
[16] C. Galasko. Mechanisms of bone destruction in the development of skeletal metastases , 1976, Nature.
[17] G. Mundy,et al. Evidence for the secretion of an osteoclast stimulating factor in myeloma. , 1974, The New England journal of medicine.
[18] R. Milch,et al. Response of bone to tumor invasion , 1956, Cancer.
[19] D. Rose,et al. Production of epidermal growth factor and transforming growth factor‐α by the androgen‐responsive LNCaP human prostate cancer cell line , 1990, The Prostate.
[20] G. Mundy,et al. Bone resorption and turnover in health and disease. , 1987, Bone.
[21] A. Freemont,et al. An improved transilial crest bone biopsy drill for quantitative histomorphometry. , 1986, Bone.
[22] M. Chapuy,et al. Parathyroid function and vitamin D status in patients with bone metastases of prostatic origin. , 1985, Mineral and electrolyte metabolism.
[23] R. Schenk,et al. Quantitative structural analysis of human cancellous bone. , 1970, Acta anatomica.